Daniel Bensen, Chief Operating Officer at Tyra Biosciences, Inc. (TYRA), sold 251,178 shares at $16.32 ($4.1M) on 2025-11-19, disclosed to the SEC on 2025-11-19.
Scheduled sale ($4.1M) by Chief Operating Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $16.07 | 75,633 | $1.2M | 29.9% |
| 2 | $16.07 | 75,633 | $1.2M | 29.9% |
| 3 | $16.32 | 49,956 | $815K | 20.1% |
| 4 | $16.32 | 49,956 | $815K | 20.1% |
| Total | $16.17 avg | 251,178 | $4.1M | 100% |
| Filing → |
| TYRA | SELL | 2025-12-16 | $181K | — | Filing → |
| TYRA | SELL | 2025-11-17 | $4.2M | — | Filing → |
| TYRA | SELL | 2024-06-10 | $74K | — | Filing → |